Learn About Late-Onset Retinal Degeneration
- Late-onset retinal degeneration
- Autosomal dominant late-onset retinal degeneration
- LORD
- Pigmentary retinopathy
- Retinal degeneration, late-onset, autosomal dominant
Vitreous Retina Macula Consultants Of New York(Downtown)
Richard Spaide is an Ophthalmologist in New York, New York. Dr. Spaide is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Central Serous Chorioretinopathy, and Vitrectomy.
Vitreous Retina Macula Consultants Of New York
Lawrence Yannuzzi is an Ophthalmologist in New York, New York. Dr. Yannuzzi is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.
Duke Health Integrated Practice Inc
Glenn Jaffe is an Ophthalmologist in Durham, North Carolina. Dr. Jaffe is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Trabeculectomy. Dr. Jaffe is currently accepting new patients.
Summary: The Phase 1 safety study of VOY-101 comprises of escalating dose Cohorts, followed by a Phase 2a.
Summary: The main objective of the study is evaluation of the safety and tolerability of RPESC-RPE-4W as therapy for dry AMD.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center